The present disclosure relates generally to providing assistances to stay healthy; and m ore specifically, to system s and m ethods for determ ining lifestyle regim e for users.

BACKGROUND

Over the years with change in lifestyle, people have becom e prone to several diseases such as m etabolic disorders. Generally, patients with diseases like diabetes require continuous diagnosis and assistance to stay healthy. Typically, diabetic patients regularly visit doctors for assistances that includes m edical and lifestyle recom m endations to m aintain a healthy blood glucose level.

Conventionally, lifestyle recom m endations are based on inputs provided by the patient. Such inputs include inform ation such as nutrients consumed, calories burnt, steps walked, physiological condition and the like. However, the conventional process of providing lifestyle recom m endations is largely dependent on the patients manually providing or inputting the information. Therefore, such technique of providing lifestyle recom m endations is inherently flawed as it is dependent on manual intervention of the patients. Consequently, the process of generating the lifestyle recom m endations is inefficient and am biguous. Moreover, readings from electronic device, used to monitor the physiological conditions of the patients are manually provided or entered to generate lifestyle recom mendations. For exam ple, electronic device such as glucom eter are used to m easure blood glucose level in the patient. However, operating such conventional electronic device is cum bersome. For exam ple, the conventional glucom eter requires large electric batteries m aking the glucom eter bulky and unfriendly. Moreover, the conventional glucometer displays information in a condensed form owing to the small size of its display.

Therefore, in light of the foregoing discussion, there exists a need to overcome the aforementioned drawbacks associated with providing life style recommendation to the user.

SUMMARY

The present disclosure seeks to provide a system for determining a lifestyle regime for a user. The present disclosure also seeks to provide a method for determining a lifestyle regime for a user. The present disclosure seeks to provide a solution to the existing problem of determining lifestyle regime based on manual intervention by the user. An aim of the present disclosure is to provide a solution that overcomes at least partially the problems encountered in prior art, and provides system for determining lifestyle regime with least dependency on manual intervention.

In one aspect, an embodiment of the present disclosure provides a system for determining a lifestyle regime for a user, the system comprising:

- a user device comprising a user agent module, wherein the user agent module is configured to generate a user interface to be displayed on a screen of the user device, and receive user input data from the user;

- a blood glucose measuring device communicably coupled to the user device for operation, wherein the blood glucose measuring device comprising

an electronic strip port for generating an electronic signal based on an electrochemical reaction occurring on a biochemical strip removably coupled therein;

a temperature sensor for sensing ambient temperature; and a control unit configured to com pute a blood glucose level based on the electronic signal received from the electronic strip port and the am bient tem perature received from the tem perature sensor, wherein the control unit is further configured to provide the user device with the blood glucose level to be displayed on the user interface; and

- a data aggregating arrangem ent com m unicably coupled to the user device for receiving the blood glucose level and the user input data provided by the user agent m odule, and to process the blood glucose level and the user input data using one or more algorithm s to determ ine the lifestyle regim e for the user and display the lifestyle regim e on the user interface of the user device.

I n another aspect, an embodiment of the present disclosure provides a m ethod for determ ining a lifestyle regime for a user, the method being implemented via a system com prising:

- a user device com prising a user agent m odule, wherein the user agent m odule is configured to generate a user interface to be displayed on a screen of the user device, and receive user input data from a corresponding user;

- blood glucose m easuring device com m unicably coupled to the user device for operation, wherein the blood glucose m easuring device comprising

an electronic strip port for generating an electronic signal based on an electrochem ical reaction occurring on the biochem ical strip rem ovably coupled therein ;

a tem perature sensor for sensing am bient tem perature; and a control unit configured to com pute a blood glucose level based on the electronic signal received from the electronic strip port, and the am bient tem perature received from the tem perature sensor, wherein the control unit is further configured to provide the user device with the blood glucose level to be displayed on the user interface; and

- a data aggregating arrangem ent com m unicably coupled to the user device for receiving the blood glucose level and the user input data provided by the user agent m odule, and to process the blood glucose level and the user input data using one or more algorithm s to determ ine the lifestyle regim e for the user and display the lifestyle regim e on the user interface of the user device. Em bodiments of the present disclosure substantially elim inate or at least partially address the aforementioned problem s in the prior art, and enables an efficient and accurate determ ination of lifestyle regim e with least dependency on m anual intervention of the user.

Additional aspects, advantages, features and objects of the present disclosure would be m ade apparent from the drawings and the detailed description of the illustrative em bodiments construed in conj unction with the appended claim s that follow.

I t will be appreciated that features of the present disclosure are susceptible to being com bined in various com binations without departing from the scope of the present disclosure as defined by the appended claims.

BRI EF DESCRI PTI ON OF THE DRAWI NGS

The sum m ary above, as well as the following detailed description of illustrative em bodiments, is better understood when read in conj unction with the appended drawings. For the purpose of illustrating the present disclosure, exem plary constructions of the disclosure are shown in the drawings. However, the present disclosure is not lim ited to specific m ethods and instrumentalities disclosed herein. Moreover, those in the art will understand that the drawings are not to scale. Wherever possible, like elements have been indicated by identical numbers.

Embodiments of the present disclosure will now be described, by way of example only, with reference to the following diagrams wherein:

FIG. 1 is a block diagram of a system for determining a lifestyle regime for a user, in accordance with an embodiment of the present disclosure;

FIG. 2 is a schematic illustration of an environment for determining a lifestyle regime for a user, in accordance with an embodiment of the present disclosure;

FIG.3 is an illustration of exemplary user interface of a user device, in accordance with an embodiment of the present disclosure; and

FIG.4 is an illustration of steps of a method for determining a lifestyle regime for a user, in accordance with an embodiment of the present disclosure.

In the accompanying drawings, an underlined number is employed to represent an item over which the underlined number is positioned or an item to which the underlined number is adjacent. A non-underlined number relates to an item identified by a line linking the non-underlined number to the item. When a number is non-underlined and accompanied by an associated arrow, the non-underlined number is used to identify a general item at which the arrow is pointing.

DETAILED DESCRIPTION OF EMBODIMENTS The following detailed description illustrates embodiments of the present disclosure and ways in which they can be implemented. Although some modes of carrying out the present disclosure have been disclosed, those skilled in the art would recognise that other embodiments for carrying out or practicing the present disclosure are also possible. In one aspect, an embodiment of the present disclosure provides a system for determining a lifestyle regime for a user, the system comprising:

- a user device comprising a user agent module, wherein the user agent module is configured to generate a user interface to be displayed on a screen of the user device, and receive user input data from the user;

- a blood glucose measuring device communicably coupled to the user device for operation, wherein the blood glucose measuring device comprising

an electronic strip port for generating an electronic signal based on an electrochemical reaction occurring on a biochemical strip removably coupled therein;

a temperature sensor for sensing ambient temperature; and a control unit configured to compute a blood glucose level based on the electronic signal received from the electronic strip port and the ambient temperature received from the temperature sensor, wherein the control unit is further configured to provide the user device with the blood glucose level to be displayed on the user interface; and

- a data aggregating arrangement communicably coupled to the user device for receiving the blood glucose level and the user input data provided by the user agent module, and to process the blood glucose level and the user input data using one or more algorithms to determine the lifestyle regime for the user and display the lifestyle regime on the user interface of the user device.

In another aspect, an embodiment of the present disclosure provides a method for determining a lifestyle regime for a user, the method being implemented via a system comprising:

- a user device comprising a user agent module, wherein the user agent module is configured to generate a user interface to be displayed on a screen of the user device, and receive user input data from a corresponding user;

- blood glucose m easuring device com m unicably coupled to the user device for operation, wherein the blood glucose m easuring device comprising

an electronic strip port for generating an electronic signal based on an electrochem ical reaction occurring on the biochem ical strip rem ovably coupled therein ;

a tem perature sensor for sensing am bient tem perature; and a control unit configured to com pute a blood glucose level based on the electronic signal received from the electronic strip port, and the am bient tem perature received from the tem perature sensor, wherein the control unit is further configured to provide the user device with the blood glucose level to be displayed on the user interface; and

- a data aggregating arrangem ent com m unicably coupled to the user device for receiving the blood glucose level and the user input data provided by the user agent m odule, and to process the blood glucose level and the user input data using one or more algorithm s to determ ine the lifestyle regim e for the user and display the lifestyle regim e on the user interface of the user device.

The present disclosure provides a system for providing lifestyle recom m endations to patients. The system com prises the user device and the blood glucose measuring device. The user device is configured to receive inputs from patient and the blood glucose measuring device is configured to com pute blood glucose level of the patient. The system employs the blood glucose level and the inputs from the patient to provide lifestyle recom mendations to the patient. The blood glucose level is directly provided by the blood glucose m easuring device to the user device without the patient manually providing or entering the blood glucose level on the user device. Consequently, the process of generating the lifestyle recom m endations by the system is efficient and accurate. The blood glucose m easuring device is dependent on the user device for providing power for its operation. The blood glucose measuring device does not employ large electric batteries and thereby is compact, light in weight and portable. The lifestyle recom m endations are provided to the patient in an elaborated form on the screen of the user device.

The present disclosure provides the system for determ ining the lifestyle regim e for the user. The system is a collection of one or m ore interconnected program mable and/or non-program m able components configured to determ ine the lifestyle regime for the user. Exam ples include program m able and/or non-program m able com ponents, such as processors, memories, connectors, cables and the like. Moreover, the program m able components are configured to store and execute one or m ore com puter instructions. Throughout the present disclosure, the term ‘user’ as used herein refers to any entity com prising a person (i.e., human being) using the system described herein. Specifically, user refers to a patient suffering from any one of: an illness, a disease, a disorder, and an ailment. I n other words, the user may be a person requiring a medical care or a person receiving the medical care or a person awaiting treatment from a physician or a person under m edical supervision from a m edically trained person. I n an exam ple, a user is a person generally having abnorm al blood glucose levels. I n such an instance, the user may be termed as a diabetic person.

Furthermore, in the present disclosure, the term regim e refers to inform ation including a schem e of conduct/ treatment that when adhered to, aids the user to m aintain a healthy condition. The regime includes inform ation related to the beginning, continuing and/or cessation of one or m ore activities in the everyday routine of the user. Exam ples of one or m ore activities may include engaging in physical activity, intaking of food, adm inistering a therapeutic agent and the like. The lifestyle regime for the user refers to information including schem e of conduct/ treatm ent that is maintained by the user in their everyday routine to retain or attain healthy condition. I n an exam ple, the lifestyle regim e m ay include inform ation of scheme of conduct/ treatment for a user having abnormal blood glucose levels. I n such example, adhering to schem e of conduct/ treatment m ay help the user attain norm al blood glucose levels, such as less than 100 m g/dL (during fasting for at least eight hours) and less than 140 m g/dL (two hours after eating) .

The system comprises the user device. The user device is any com puting device associated with (or used by) the user that is capable of enabling the user to perform specific tasks associated with the aforementioned system . Furtherm ore, the user device is intended to be broadly interpreted to com prise any electronic device that is used for voice and/or data com m unication over a com m unication network. Examples of user device comprise, but are not lim ited to, cellular phones, personal digital assistants ( PDAs) , handheld devices, laptop com puters, personal com puters, sm art watches and the like. Additionally, the user device comprises a m em ory unit, a processor, a network interface card, a connecting port and the like.

The user device com prises the user agent module, wherein the user agent m odule is configured to generate the user interface to be displayed on the screen of the user device, and receive user input data from the user. The user agent m odule refers to a com puter program or a routine that is configured to generate the user interface to enable com m unication between the system and the user. Furthermore, the user agent m odule comprises one or more routines, data structures, object classes, and/or protocols that support the interaction of the user device and the user. It will be appreciated that the user agent module invokes system -level code or calls to other software residing on the user device or other location com m unicatively coupled with the user device to perform certain functions, such as setting up a com m unication session between the user device, the blood glucose m easuring device and/or the data aggregating arrangem ent. I n an exam ple, a user agent module is a software application that operates on any form of computing device, such as the user device, and that is capable of accessing static data or resource files stored in the user device, such as user-viewable hypertext docum ents.

Moreover, the user agent m odule when initiated or interacted with provides the user interface to be displayed on the screen of the user device. The user interface includes a structured set of user interface elem ents rendered on the screen of the user device. The user interface elements refer to visual objects that have a size and a position in the user interface. Exam ples of user interface elem ents include (but are not lim ited to) text blocks, labels, text boxes, list boxes, lines, and im age windows, dialog boxes, fram es, panels, m enus, buttons, icons, and the like. I n addition to size and position, the user interface elem ents may have other properties, such as a m argin, spacing, or the like. Furtherm ore, the user interface elements are used by the user to interact with the user device to enter user input data. The user input data is the inform ation provided by the user while interacting with the system via the user interface of the user device. For example, a given user interface elem ent m ay include a text box that is configured to receive textual input from the user, such as a nam e of the user or the age of the user. I n such exam ple, the given user interface elem ent enables the user to input the user input data and receive the user input data from the user. Optionally, a user interface elem ent m ay generally be visible, though there m ay be tim es when a user interface elem ent is hidden. Optionally, the user interface used herein is a graphical user interface (GUI ) .

The system com prises the blood glucose m easuring device. Throughout the present disclosure, the term“blood glucose measuring device” refers to a m edical device for m easuring a concentration or an am ount of glucose present in blood of the user. Typically, the blood glucose measuring device is a compact device having a small size enabling the user to conveniently utilise and carry the blood glucose measuring device. In an example, the blood glucose measuring device has a weight of 25 grams and a diameter of 40 millimetre. The concentration or amount of glucose present in the blood is referred to as blood glucose level. Optionally, a predefined concentration of glucose in the blood is desired for a good health of the user. In an example, a desirable blood glucose level for good health of an adult user (having an age more than 18 years) is below 100 mg/dL (milligram per deciliter) before the adult user consumes food and the blood glucose level two hours after the adult user consumes food is less than 140 mg/dL. The blood glucose measuring device enables the user to continuously measure the blood glucose levels and based on the measurements of the blood glucose levels the user may take necessary actions such as diet control, medication to maintain the desired blood glucose level. Optionally, the blood glucose measuring device accurately measures the blood glucose level in a range of 30 mg/dL (milligram per deciliter) to 600 mg/dL (milligram per deciliter). More optionally, the blood glucose measuring device accurately measures the blood glucose level in a range of 1.665 mmol/L (millimoles per liter) to 33.3 mmol/L (millimoles per liter).

The blood glucose measuring device is communicably coupled to the user device for operation. Specifically, the blood glucose measuring device is configured in a manner that the blood glucose measuring device starts or activates to perform one or more functions. Moreover, the one or more functions that are performed by the blood glucose measuring device enables measurement of the blood glucose levels of the user. In an example, the coupling of the user device with the blood glucose measuring device enables the user device to control a start of measurement of blood glucose levels. In an embodiment, the blood glucose measuring device is communicably coupled to the user device via a connecting means. The term connecting means herein refers to a wired or a wireless connection between the blood glucose measuring device and the user device via which the user device controls the operation of the blood glucose measuring device. In an example, the connecting means may be a USB (Universal Serial Bus) or MICRO USB (Universal Serial Bus) cable. In such an example, the USB (Universal Serial Bus) or MICRO USB (Universal Serial Bus) cable may be a USB (Universal Serial Bus) or MICRO USB (Universal Serial Bus) standard A connector or a USB (Universal Serial Bus) or MICRO USB (Universal Serial Bus) standard B connector or a USB (Universal Serial Bus) or MICRO USB (Universal Serial Bus) type C connector and the like. Optionally, for a connection via USB (Universal Serial Bus) or MICRO USB (Universal Serial Bus) cable, the user device and the blood glucose measuring device comprise a female connecting unit to receive a male connecting unit present at both ends of the USB (Universal Serial Bus) or MICRO USB (Universal Serial Bus) cable. In another example, the connecting means may be an auxiliary input cable. In such an example, the auxiliary input cable may have a plug of diameter 6.35mm (millimetre), or a plug of diameter 3.5 mm (millimetre) or a plug of diameter 2.5 mm (millimetre). Optionally, for a connection via Auxiliary input cable, the user device and the blood glucose measuring device comprise a jack to receive plugs of the Auxiliary input cable for establishing a connection thereof. I n yet another example, the wireless connecting means may comprise connections via Internet, Bluetooth, NFC (Near Field Communication). In such an example, the user device and the blood glucose measuring device comprise wireless connectivity modules such as Internet module, Bluetooth module, NFC (Near Field Communication) module. In another example, the connecting means may be a Lightning® (connector).

Optionally, the blood glucose measuring device comprises a UART (Universal asynchronous receiver-transmitter) interface. In such a case, a USB (Universal Serial Bus) to UART (Universal asynchronous receiver- transm itter) bridge controller is em ployed in the blood glucose measuring device to enable the user to connect the user device to the blood glucose m easuring device via the USB (Universal Serial Bus) connecting m eans.

I n an em bodim ent, the blood glucose measuring device is a passive device. The blood glucose measuring device requires power for perform ing its operations. Specifically, the power required by the blood glucose m easuring device is provided by the user device. Moreover, the connectivity m eans enables the user device to provide the power to the blood glucose m easuring device. I n an example, the blood glucose m easuring device is provided power by the user device upon receiving a start instruction from the user device. I n another example, the blood glucose measuring device receives power from the user device via the USB ( Universal Serial Bus) cable. I n yet another example, the blood glucose measuring device receives power from the user device wirelessly via induction charging.

I n an em bodim ent, the blood glucose m easuring device does not have a screen to display any information. The blood glucose m easuring device is configured to display the information to the user via the user interface displayed on the screen of the user device. For exam ple, an error inform ation describing the malfunction of the blood glucose m easuring device m ay be displayed in the user interface of the user device.

Moreover, the blood glucose m easuring device com prises the electronic strip port for generating the electronic signal based on the electrochem ical reaction occurring on the biochem ical strip rem ovably coupled therein. Typically, the user provides a blood sam ple to the blood glucose m easuring device. Moreover, the user obtains the blood sam ple by pricking a finger. I n an exam ple, a quantity of the blood sample obtained is in m icroliters. I n another example, the blood glucose m easuring device requires 0.5 m icroliters of blood sam ple for determ ination of blood glucose level. Generally, the blood sam ple is provided by the user on the biochem ical strip. Typically, the biochem ical strip com prises an enzyme referred to as glucose oxidase enzym e and a chem ical referred to as ferricyanide. Moreover, upon providing the blood sample on the biochem ical strip, the glucose present in the blood undergoes electrochem ical reaction with the glucose oxidase enzym e to produce gluconic acid. Furtherm ore, the gluconic acid undergoes electrochem ical reaction with ferricyanide to produce ferrocyanide. The ferrocyanide produced on the biochem ical strip generates electronic signals which increases the electronic power used in the electronic strip port. Consequently, a change in the electronic power provided by the blood glucose measuring device enables the determ ination of the electronic signal generated by the electrochem ical reaction. Additionally, the removable coupling of the biochem ical strip with the electronic strip enables the user to replace the biochem ical strip upon the generation of the electronic signal.

Furthermore, the blood glucose m easuring device com prises the temperature sensor for sensing ambient tem perature. Throughout the present disclosure, the term “ambient temperature” refers to a temperature of the air in an environment comprising the user and the blood glucose measuring device. The ambient tem perature is essential for determ ination of accurate blood glucose levels of the user. I n an exam ple, an am bient temperature may be a room temperature such as 20 degree Celsius. Moreover, the concentration of glucose present in the blood of the user varies based on the ambient temperature. Furthermore, a dependency of the concentration of glucose on the tem perature results in production of an incorrect electronic signal. The blood glucose m easuring device may generate an incorrect blood glucose levels based on the incorrect electronic signal. Therefore, the am bient temperature is significant in determ ination of correct blood glucose levels of the user. Optionally, the tem perature sensor converts the ambient tem perature into a corresponding electronic digital signal. Optionally, the temperature sensor is configured to accurately sense the ambient tem perature in a range of 1 degree Celsius to 45 degree Celsius.

Moreover, the blood glucose m easuring device comprises the control unit configured to com pute the blood glucose level based on the electronic signal received from the electronic strip port and the am bient temperature received from the temperature sensor. Throughout the present disclosure, the term ‘control unit’ refers to a computational elem ent that is operable to respond to and processes instructions that drive the blood glucose m easuring device. Optionally, the control unit comprises, but is not lim ited to, a m icroprocessor, a m icrocontroller, a com plex instruction set com puting (CI SC) m icroprocessor, a reduced instruction set (RI SC) m icroprocessor, a very long instruction word (VLIW) m icroprocessor, or any other type of processing circuit. Moreover, the term “control unit” m ay refer to one or m ore individual processors, processing devices and various elem ents associated with a processing device that m ay be shared by other processing devices. Additionally, the one or m ore individual processors, processing devices and elem ents are arranged in various architectures for responding to and processing the instructions that drive the blood glucose m easuring device. Optionally, the control unit is operable to com pute the blood glucose level in a processing time of less than or equal to five seconds.

I n an em bodim ent, the control unit is configured to employ one or m ore derived regression equations for computing the blood glucose level. The one or m ore derived regression equations facilitates a relationship between the ambient tem perature and the electronic signal to determ ine an accurate blood glucose level irrespective of the variations in the am bient temperature. I n an exam ple, the blood glucose m easuring device determ ines the blood glucose level of a patient to be 150 m g/dL (m illigram per deciliter) at an am bient tem perature of 30 degree Celsius. I n such an exam ple, the blood glucose measuring device determ ines the blood glucose level of the patient to be 1 50 m g/dL (m illigram per deciliter) even at an ambient temperature of 40 degree Celsius. Therefore, the one or more derived regression equations enables the blood glucose m easuring device to efficiently determ ine a sim ilar blood glucose level for the user even in different ambient temperature.

Moreover, the control unit is further configured to provide the user device with the blood glucose level to be displayed on the user interface. The blood glucose level is provided to the user device via the connecting m eans. The user device enables the user to view the blood glucose level determ ined by the blood glucose measuring device. I n an em bodim ent, the user interface comprises one or more user interface elements to control the operation of the blood glucose measuring device. I n an exam ple, the one or more user interface elem ents enable the user to provide a wake up com m and to the blood glucose measuring device by clicking on a wake up text block on the user interface. I n another exam ple, the one or more user interface elem ents enable the user to receive an acknowledgm ent from the blood glucose measuring device via a green button on the user interface. I n yet another example, the one or m ore user interface elem ents enable the user to receive an instruction from the blood glucose measuring device for insertion of biochem ical strip. I n another example, the one or more user interface elements enable the user to receive an acknowledgm ent from the blood glucose m easuring device about acceptance of the biochem ical strip. I n yet another example, the one or m ore user interface elem ents enable the user to instruct the blood glucose measuring device to start operation.

The system com prises the data aggregating arrangem ent com m unicably coupled to the user device for receiving the blood glucose level and the user input data provided by the user agent module. Throughout the present disclosure, the term“data aggregating arrangement” refers to an arrangem ent comprising a com putational entity configured to acquire, process and/or respond to the blood glucose level and the user input data provided by the user agent module of the user device. Optionally, the data aggregating arrangement includes one or more programmable and non-programmable components. Examples of the one or more programmable and non-programmable components may include memory, processor, network adapter, cabinets, crisscrossed wires, connector and the like. Moreover, the one or more programmable and non-programmable components of data aggregating arrangement are configured to host computer programs and/or routines that provide various services. In one example, the services may include providing connectivity between the data aggregating arrangement and the user device for establishing a communication session and subsequently receiving the blood glucose level and the user input data from the user agent module. In another example, the services may include providing a data repository service for storing the information related to the user. In yet another example, the services may include hosting computer programs and/or routines for processing the one or more inputs received from the user agent module. The data aggregating arrangement is communicably coupled to the user device via a data network. Examples of the data network may include, but is not limited to, one or more peer- to-peer network, a hybrid peer-to-peer network, local area networks (LANs), radio access networks (RANs), wide area networks (WANs), portions of a public network such as the Internet, a cellular network and the like. Optionally, the data aggregating arrangement and the user device are operable to exchange information related to the user carried out via any number of known protocols suitable for exchanging information including voice, video, data and combinations thereof. Examples of the protocols may include, but not limited to, Internet Protocol (IP), Wireless Access Protocol (WAP), Frame Relay, or Asynchronous Transfer Mode (ATM). I n an embodiment, the user input data com prises personal inform ation of the user. The personal inform ation of the user includes demographical details, connectivity details, financial details, career details, health details, and the like. I n an exam ple, the dem ographical details of the user m ay include date of birth, age, gender, address, location , num ber of fam ily mem bers, religion, citizenship, and the like; the connectivity details of the user m ay include a phone num ber, an em ail address of the user, and the like; the financial details of the user m ay include bank account num ber, the vendor details of which the user uses the banking services, debit or credit card num ber and the like; the career details associated to the user m ay include job designation, total amount of experience, current salary, and the like; the health details associated to the user m ay include weight, height, body m ass index, major disorders, and the like.

I n an em bodim ent, the personal information of the user is acquired by the data aggregating arrangem ent from a third-party service provider. The third-party service provider refers to one or m ore systems, applications, and/or a combination thereof for providing electronic content (namely, the data describing the personal inform ation of the user) to the data aggregating arrangement via the data network. Furtherm ore, the third-party service provider is subscription based, i.e. the data describing the personal inform ation of the user is provided as an online service that is accessed by the data aggregating arrangement with subscriber accounts.

I n an em bodim ent, the user input data com prises inform ation describing food intake of the user and its corresponding tim ings. The information describing the food intake of the user and its corresponding tim ings refers to an amount and type of the food consum ed by user, and the corresponding tim ings refers to the time at which the am ount and the type of the food is consum ed by user. For example, the am ount m ay be measured in various units such as grams, kilograms, calories and the like, and type may describe the category of food, such as organic, non- organic, vegan, vegetarian, non-vegetarian and the like. In such example, the corresponding timing may describe the time of the 24 hours at which the user is consuming the food, such as at 0600 hours, 0800 hours, 1300 hours, 1700 hours, 2000 hours and 2200 hours.

In an embodiment, the user input data comprises information describing physical activity performed by the user. The information describing the physical activity performed by the user refers to the movement of the user in one or more direction. For example, the movements may include the daily movements, such as walking, running, swimming, sleeping or other activity. It may be appreciated that a sensor arrangement may be communicatively coupled with the user device to provide data related to the physical activity performed by the user, that is further processed by the user agent application and thereafter transmitted to the data aggregating arrangement via the data network.

In an embodiment, the user input data comprises information describing medication consumed by the user. The information describing the medication consumed by the user includes the details of the one or more medicines consumed by the user. Moreover, the information describing the medication consumed by the user includes time at which the user consumes the medicine. For example, the information describing the medication consumed by the user may describe that the user consumes the medicine 'W 20 minutes before 0600 hours, the medicine 'X' 10 minutes before 1300 hours, the medicine Ύ 10 minutes before 2000 hours, and the medicine 'Z' 10 minutes after 2200 hours.

In an embodiment, the data aggregating arrangement includes a database, wherein the database is configured to store the received blood glucose level and the user input data at one or more specific data structure suitable for further computation. Examples of the data structure m ay include a table, a map, a grid, a packet, a datagram , a file, a docum ent, a list or any other form . The database may be hardware, software, firmware and/or any com bination thereof. For example, the database may include any data storage software and system s, such as, for exam ple, a relational database like I BM DB2 and Oracle 9. Additionally, the blood glucose level and the user input data are stored in the database in the form of data elem ents including (but are not lim ited to) data records and bits of data. It will be appreciated that, the data elem ents associated to a given user populates the database in a specific section that is assigned to the given user

The data aggregating arrangement is configured to process the blood glucose level and the user input data using one or more algorithm s. The one or more algorithm s are any collection or set of instructions executable by a computer or other digital system so as to configure the data aggregating arrangement to analyze the blood glucose level and the user input data. Additionally, the one or m ore algorithms is intended to encom pass such instructions stored in storage medium such as RAM, a hard disk, optical disk, or so forth, and is also intended to encom pass so- called“firmware” that is software stored on a ROM or so forth. Optionally, the one or more algorithm s refer to software application. Such one or m ore algorithm s is organized in various ways, for example the one or m ore algorithms includes software com ponents organized as libraries, I nternet-based program s stored on a remote server or so forth, source code, interpretive code, object code, directly executable code, and so forth. I t m ay be appreciated that the one or m ore algorithm s m ay invoke system -level code or calls to other software residing on a server or other location to perform certain functions. Furtherm ore, the one or m ore algorithms may be pre-configured and pre-integrated with an operating system of the data aggregating arrangem ent. Moreover, the one or m ore algorithm s are artificial intelligence (Al ) algorithm s. Specifically, the one or m ore algorithm s are executable upon the data aggregating arrangement, and are operable to adapt and adj ust their operating parameters in an adaptive m anner, depending upon inform ation that is presented thereto when executed. Thus, by learning by exam ple from a given blood glucose level and a given user input data, neural networks and variable state engines of the artificial intelligence (Al ) algorithms are thereby program m ed to analyze the given blood glucose level and the given user input data. Thus, it will be appreciated that processing of the given blood glucose level and the given user input data is perform ed in a sem i-automated or autom ated m anner.

I n an em bodiment, the data aggregating arrangement is operable to employ historical recorded data including the blood glucose level and the user input data provided by the user agent module, as an input param eter to the one or m ore algorithm s. The historical recorded data including the blood glucose level and the user input data refers to the chronologically stored data in a specific data structure including the blood glucose level and the user input data. Specifically, the historical recorded data includes each and every blood glucose level and the user input data associated to the user that was transm itted by the user agent m odule since a first use of the system . More specifically, the historical recorded data is the periodically saved blood glucose level reading and the user input data provided by the user agent m odule. For example, the first blood glucose level of a user A was L and the user input data was n 1 , n2, n3 and n4, the second blood glucose level of a user A was M and the user input data was n 1 , n2, n5 and n4, the third blood glucose level of a user A was N and the user input data was n 1 , n2, n3 and n6, the fourth blood glucose level of a user A was O and the user input data was n 1 , n2, n7 and n8, and the fifth blood glucose level of a user A was P and the user input data was n 1 , n2, n7 and n9. I n such example, the chronologically stored data of the blood glucose levels and the user input data of the user A is the historical recorded data. Furtherm ore, in such example, the one or m ore algorithms may consider the blood glucose levels L, M, N, O and P, and the user input data n 1 , n2, n3, n4, n5, n6, n7, n8 and n9, and the relations between the blood glucose levels and the user input data to process the blood glucose level and the user input data, such as a real tim e blood glucose level and the user input data. It will be appreciated that the database is configured to store the blood glucose levels and the user input data of the user chronologically.

I n an embodim ent, the one or more algorithms process the historical recorded data to determ ine trend in physiological condition of the user. The trend determ ined in the historical recorded data refers to any com m onality in the physiological condition of the user. I n an embodim ent, the trends are determ ined based on a variation in the blood glucose level of the user. The variation in the blood glucose level of the user refers to the difference in the blood glucose levels of the user. For exam ple, as m entioned in an aforesaid exam ple the first, the blood glucose level L may be greater than blood glucose level M, the blood glucose level N m ay be lesser than the blood glucose level M, the blood glucose level O m ay be lesser than the blood glucose level P, the blood glucose level O m ay be lesser than N. I n such an instance, the one or m ore algorithm s are configured to process the historical recorded data to determ ine the physiological condition of the user.

I n an em bodiment, the trends are determ ined based on a preference provided by the user. The user interface includes one or m ore user interface elem ents that enable providing specific preference of the user. I n an em bodim ent, preference provided by the user com prises a diet preference of the user. For example, the user may prefer to consume fruits. I n an embodiment, preference provided by the user com prises a daily routine preference of the user. I n an example, the daily routine preference of the user m ay be that the user prefers to have 8 hours of continuous sleep. I n an em bodim ent, preference provided by the user comprises a physical restraint of the user. I n an example, physical restraint of the user may be a fractured leg. Optionally, the preference provided by the user m ay be determ ined from the user input data. For exam ple, if the user has m entioned that the user intakes food at a specific tim e such as 1700 hours repeatedly, the user perform s physical activity for a period such as for 1 hour at 0700 hours repeatedly, or consumes m edication 10 m inutes after 2200 hours. I n such an instance, the preference provided by the user m ay be considered as the user prefers to intake food at 1700 hours, perform the physical activity for 1 hour at 0700 hours, and consum e m edication 10 m inutes after 2200hours. The one or m ore algorithms analyze the user input data describing the personal information, the food intake, the physical activity, the m edication consum ed by the user to determ ine how the body of the user reacts when the blood glucose level is L, M, N, O and P, and the preference provided by the user is considered. I n an example, the one or m ore algorithms analyze if there is a specific pattern. I n such an instance, the specific pattern may be that the user is having a user is having a blood glucose level of O when the user is consum ing fruits and sleeping for 8 hours in 24 hours.

Furthermore, the data aggregating arrangement processes the blood glucose level and the user input data using one or m ore algorithms to determ ine the lifestyle regime for the user and display the lifestyle regime on the user interface of the user device. The one or m ore algorithms are configured to generate the lifestyle regim e including a list of habits and activities based on the blood glucose level, the user input data, and the trends that may enable the user to be healthy. I t will be appreciated that healthy is a state of the user's body in which the body perform s its vital functions norm ally or properly. For example, user is having a blood glucose level of O when the user is consum ing fruits and sleeping for 8 hours in 24 hours. I n such an exam ple, the lifestyle regime determ ined by the one or more algorithms may include a 2 hours of physical activity to be performed by the user, perform food intake at 0600 hours, 0900 hours, 1200 hours, 1500 hours, 1800 hours and 2100 hours, and consume the medicine 'W 20 minutes before 0600 hours, the medicine 'X' 10 minutes before 1200 hours, the medicine Ύ 10 minutes before 1800 hours, and the medicine 'Z' 10 minutes after 2100 hours. In such an example, the user having the blood glucose level of O may be considered as healthy. Moreover, in such an example, the user continues to be healthy by considering the lifestyle regime determined by the one or more algorithms. Furthermore, the aforementioned information is transmitted by the data aggregating arrangement to the user device, and subsequently displayed in the user interface of the user agent module in the form of user interface elements.

DETAILED DESCRIPTION OF THE DRAWINGS

Referring to FIG.1, there is shown a block diagram of a system 100 for determining a lifestyle regime for a user, in accordance with an embodiment of the present disclosure. As shown, the system 100 comprises a user device 102, a blood glucose measuring device 104, and a data aggregating arrangement 106. Moreover, the blood glucose measuring device 104 is communicably coupled to the user device 102 for operation. Furthermore, the data aggregating arrangement 106 is communicably coupled to the user device 102.

Referring to FIG. 2, there is shown a schematic illustration of an environment 200 for determining a lifestyle regime for a user, in accordance with an embodiment of the present disclosure. As shown, the environment 200 comprises a blood glucose measuring device 202 communicably coupled to a user device 204 a connecting means 206. The user device 204 is configured to receive user input data from a corresponding user. The blood glucose measuring device 202 is configured to compute a blood glucose level and provide the user device 204 with the blood glucose level. As shown, the user device 204 is com m unicably coupled to the data aggregating arrangem ent 208. The data aggregating arrangement 208 is configured to receive the blood glucose level and the user input data from the user device 204 and store the blood glucose level and the user input data in a database 21 0. Moreover, the data aggregating arrangem ent 208 determ ines the lifestyle regim e for the user and displays the lifestyle regime on the user device 204.

Referring to FI G. 3, there is shown an illustration of exem plary user interface of a user device 300 , in accordance with an embodiment of the present disclosure. The user device 300 com prises a user agent module. Moreover, the user agent m odule is configured to generate a user interface 302 to be displayed on a screen of the user device and receive user input data from a user. As shown, the user interface 302 receives user input data in form of preferences depicted as a diet preference 304 of the user; a daily routine preference 306 of the user; and a physical restraint 308 of the user. Moreover, the user interface 302 comprises a user interface elem ent 31 0 to control a start operation of the blood glucose m easuring device.

Referring to FI G. 4, there is shown an illustration of steps of a m ethod 400 for determ ining a lifestyle regim e for a user, in accordance with an embodim ent of the present disclosure. The method 400 is implemented via a system comprising a user device, a blood glucose m easuring device, and a data aggregating arrangem ent. The blood glucose m easuring device com prises an electronic strip port, a tem perature sensor, and a control unit. At a step 402 , an electronic signal is generated based on an electrochem ical reaction occurring on a biochem ical strip rem ovably coupled to the electronic strip port. At a step 404 , an am bient temperature is sensed by the temperature sensor. At a step 406 , a blood glucose level is computed, by the control unit, based on the electronic signal received from the electronic strip port and the ambient temperature received from the temperature sensor. At a step 408, the blood glucose level and the user input data are received by the data aggregating arrangement, and the blood glucose level and the user input data are processed using one or more algorithms to determine the lifestyle regime for the user and display the lifestyle regime on the user device.

The steps 402 to 408 are only illustrative and other alternatives can also be provided where one or more steps are added, one or more steps are removed, or one or more steps are provided in a different sequence without departing from the scope of the claims herein.

Modifications to embodiments of the present disclosure described in the foregoing are possible without departing from the scope of the present disclosure as defined by the accompanying claims. Expressions such as “including”, “comprising”, “incorporating”, “have”, “is” used to describe and claim the present disclosure are intended to be construed in a non exclusive manner, namely allowing for items, components or elements not explicitly described also to be present. Reference to the singular is also to be construed to relate to the plural.